PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24728097-2	2014	Previous studies with small sample size have reported higher circulating MMP-2 and MMP-9 levels in patients with TBI, but no association between those levels and mortality.	Thioacetazone	113-116	matrix metallopeptidase 9	Homo sapiens	83-88	
24728097-14	2014	CONCLUSIONS: The most relevant and new findings of our study, the largest series reporting data on TIMP-1 and MMP-9 levels in patients with severe TBI, were that serum TIMP-1 levels were associated with TBI mortality and could be used as a prognostic biomarker of mortality in TBI patients.	Thioacetazone	147-150	matrix metallopeptidase 9	Homo sapiens	110-115	
24728097-14	2014	CONCLUSIONS: The most relevant and new findings of our study, the largest series reporting data on TIMP-1 and MMP-9 levels in patients with severe TBI, were that serum TIMP-1 levels were associated with TBI mortality and could be used as a prognostic biomarker of mortality in TBI patients.	Thioacetazone	203-206	matrix metallopeptidase 9	Homo sapiens	110-115	
24728097-14	2014	CONCLUSIONS: The most relevant and new findings of our study, the largest series reporting data on TIMP-1 and MMP-9 levels in patients with severe TBI, were that serum TIMP-1 levels were associated with TBI mortality and could be used as a prognostic biomarker of mortality in TBI patients.	Thioacetazone	203-206	matrix metallopeptidase 9	Homo sapiens	110-115	
24728097-3	2014	Thus, the aim of this study was to determine whether serum TIMP-1 and MMP-9 levels are associated with mortality in patients with severe TBI.	Thioacetazone	137-140	matrix metallopeptidase 9	Homo sapiens	70-75	
30802757-1	2019	PURPOSE: Previously, higher circulating levels of matrix metalloproteinase (MMP)-9 and tissue inhibitor matrix metalloproteinases (TIMP)-1 were reported in the first hours after TBI in blood samples from patients with poor prognosis.	Thioacetazone	178-181	matrix metallopeptidase 9	Homo sapiens	50-82	
30802757-2	2019	Thus, the objectives of this study were to determine whether MMP-9 and TIMP-1 levels during the first week of a severe TBI could be used as biomarker predictive of mortality.	Thioacetazone	119-122	matrix metallopeptidase 9	Homo sapiens	61-66